SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new trial‑related updates.
Stocktwits on MSN
Why is SLS stock drawing significant investor attention today?
The company said that 72 out of the prespecified 80 deaths required to trigger the final analysis have now occurred as of Dec ...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
SELLAS Life Sciences Group (SLS) is back on traders’ radar after fresh data from its leukemia program, including strong response rates and supportive FDA designations, helped spark a sharp move in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback